Study details
Enrolling now
A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
VIVUS LLC
NCT IDNCT06915246ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
49
Study length
about 1.1 years
Ages
18+
Locations
4 sites in AZ, CA, GA +1
Why this study is shown
Matches lymphomaActively enrollingPHASE2
What this study is about
Researchers are testing a treatment (VI-0609) compared to another treatment (BiCNU) for lymphoma. The trial will last about 414 days, involving approximately 49 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take BiCNU
- 2.Take VI-0609
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Oncology